Skip to content

Luke Evnin, 10% owner at Entrada Therapeutics, sold TRDA on Sep 2, 2026

Data as of Oct 16

▼ SELL$181K25,131 shares at $7.19Luke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.
Watch TRDA
Traded
Sep 2, 2026
Disclosed
Sep 3, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Luke Evnin, 10% owner at Entrada Therapeutics, sold TRDA on Sep 2, 2026TRADEDDISCLOSED
TRDASimilar stocks (XLV — its sector index fund), rebased to TRDA's price on the disclosure day
TRDA since disclosure
−39.1%
after the sale
Similar stocks (XLV) since disclosure
+2.0%
XLV — its sector index fund

Change in closing price from Sep 3, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  2. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  3. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  4. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  5. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  6. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  7. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  8. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  9. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  10. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  11. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  12. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  13. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  14. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  15. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade

See every trade on TRDA →